View Item 

Show simple item record

Yohimbine bioavailability in humans

dc.contributor.authorGuthrie, Sally K.en_US
dc.contributor.authorGrunhaus, Leon J.en_US
dc.contributor.authorHariharan, Meenatshisundananen_US
dc.date.accessioned2006-09-11T18:01:41Z
dc.date.available2006-09-11T18:01:41Z
dc.date.issued1990-10en_US
dc.identifier.citationGuthrie, S. K.; Hariharan, M.; Grunhaus, L. J.; (1990). "Yohimbine bioavailability in humans." European Journal of Clinical Pharmacology 39(4): 409-411. <http://hdl.handle.net/2027.42/46641>en_US
dc.identifier.issn1432-1041en_US
dc.identifier.issn0031-6970en_US
dc.identifier.urihttps://hdl.handle.net/2027.42/46641
dc.identifier.urihttp://www.ncbi.nlm.nih.gov/sites/entrez?cmd=retrieve&db=pubmed&list_uids=2076728&dopt=citationen_US
dc.description.abstractPharmacokinetic profiles were determined in seven healthy young male subjects following single oral and intravenous doses of 10 mg of yohimbine hydrochloride.en_US
dc.format.extent345245 bytes
dc.format.extent3115 bytes
dc.format.mimetypeapplication/pdf
dc.format.mimetypetext/plain
dc.language.isoen_US
dc.publisherSpringer-Verlagen_US
dc.subject.otherPharmacokineticsen_US
dc.subject.otherPharmacology/Toxicologyen_US
dc.subject.otherBioavailabilityen_US
dc.subject.otherBiomedicineen_US
dc.subject.otherYohimbineen_US
dc.titleYohimbine bioavailability in humansen_US
dc.typeArticleen_US
dc.subject.hlbsecondlevelPharmacy and Pharmacologyen_US
dc.subject.hlbtoplevelHealth Sciencesen_US
dc.description.peerreviewedPeer Revieweden_US
dc.contributor.affiliationumCollege of Pharmacy and Department of Psychiatry, The University of Michigan, Ann Arbor, Michigan, USAen_US
dc.contributor.affiliationumDepartment of Psychiatry, The University of Michigan Medical School, The University of Michigan, Ann Arbor, Michigan, USAen_US
dc.contributor.affiliationumDepartment of Psychiatry, The University of Michigan Medical School, The University of Michigan, Ann Arbor, Michigan, USAen_US
dc.contributor.affiliationumcampusAnn Arboren_US
dc.identifier.pmid2076728en_US
dc.description.bitstreamurlhttp://deepblue.lib.umich.edu/bitstream/2027.42/46641/1/228_2004_Article_BF00315421.pdfen_US
dc.identifier.doihttp://dx.doi.org/10.1007/BF00315421en_US
dc.identifier.sourceEuropean Journal of Clinical Pharmacologyen_US
dc.owningcollnameInterdisciplinary and Peer-Reviewed


Files in this item

Name:
228_2004_Article_BF00315421.pdf
Size:
337.1KB
Format:
PDF
View/Open

Show simple item record

Remediation of Harmful Language

The University of Michigan Library aims to describe library materials in a way that respects the people and communities who create, use, and are represented in our collections. Report harmful or offensive language in catalog records, finding aids, or elsewhere in our collections anonymously through our metadata feedback form. More information at Remediation of Harmful Language.

Accessibility

If you are unable to use this file in its current format, please select the Contact Us link and we can modify it to make it more accessible to you.